# Evaluation of rSO2 Between Frontal Lesion Area and Normal Area of Brain by NIRSITX Using NIRS in Acute Ischemic Stroke Patients.

> **NCT06250608** · NA · COMPLETED · sponsor: **OBELAB, Inc.** · enrollment: 35 (actual)

## Conditions studied

- Acute Ischemic Stroke Patients

## Interventions

- **DEVICE:** Pulse oximeter, NIRSITX

## Key facts

- **NCT ID:** NCT06250608
- **Lead sponsor:** OBELAB, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-15
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2026-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06250608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06250608, "Evaluation of rSO2 Between Frontal Lesion Area and Normal Area of Brain by NIRSITX Using NIRS in Acute Ischemic Stroke Patients.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06250608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*